Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bone Biologics Corp (BBLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3049
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The company’s technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with manufacturing organizations to develop its products. The company markets its products domestic and internationally. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

Bone Biologics Corp (BBLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bone Biologics Raises USD5 Million in Venture Financing 11
Merger 12
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Equity Offering 13
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 14
Debt Offering 15
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 15
Bone Biologics Corp – Key Competitors 16
Bone Biologics Corp – Key Employees 17
Bone Biologics Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Director 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bone Biologics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Raises USD5 Million in Venture Financing 11
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 14
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 15
Bone Biologics Corp, Key Competitors 16
Bone Biologics Corp, Key Employees 17

List of Figures
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Albéa Beauty Holdings S.A.:戦略・SWOT・企業財務分析
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sequella Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sequella Inc (Sequella) is a clinical-stage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company’s pipeline products comprise SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid antibiotic susceptibility test, B-SMART. S …
  • Rose Petroleum plc (ROSE):企業の財務・戦略的SWOT分析
    Summary Rose Petroleum Plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • Southern Maryland Electric Cooperative Inc:発電所・企業SWOT分析
    Southern Maryland Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, infor …
  • New York Blood Center:製薬・医療:M&Aディール及び事業提携情報
    Summary New York Blood Center (NYBC) is a non-profit healthcare organization that offers blood collection and distribution. The organization's blood products comprise red blood cells, plasma products, platelets, frozen blood and washed products, whole blood and granulocytes. It offers medical servic …
  • Gibson Energy Inc (GEI)-石油・ガス分野:企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FP Corporation:企業の戦略・SWOT・財務情報
    FP Corporation - Strategy, SWOT and Corporate Finance Report Summary FP Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company developing folate-based therapies for the treatment of cancer patients. The company’s clinical lead candidate Modufolin, a metabolite is under clinical phase I/II development being evaluated for the treatment of colorectal …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析2018
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Hochdorf Holding AG (HOCN):企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Murphy Oil Corp (MUR):企業の財務・戦略的SWOT分析
    Murphy Oil Corp (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …
  • Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuway Pharma GmbH (Neuway) is a provider of preclinical and clinical development for the treatment of central nervous system diseases. The company provides proprietary CNS drug delivery platform facilitates the transport of active drug substances through the blood-brain barrier. Its technol …
  • Consolis SAS:企業の戦略・SWOT・財務情報
    Consolis SAS - Strategy, SWOT and Corporate Finance Report Summary Consolis SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Baltimore Gas and Electric Company:発電所・企業SWOT分析
    Baltimore Gas and Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • TIBCO Software, Inc.:企業のM&A・事業提携・投資動向
    TIBCO Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TIBCO Software, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • China National Nuclear Power Co Ltd (601985):電力:M&Aディール及び事業提携情報
    Summary China National Nuclear Power Co Ltd (CNNPC), a subsidiary of China National Nuclear Corp is a nuclear energy company. The company provides activities such as development, investment, construction, operations and management of nuclear power projects and technical research in the safe operatio …
  • Sokolovska uhelna, pravni nastupce, A.S.:企業の戦略的SWOT分析
    Sokolovska uhelna, pravni nastupce, A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Aspen Pharmacare Holdings Ltd (APN):企業の財務・戦略的SWOT分析
    Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆